Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women
- 12 November 2021
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 28 (3), 237-242
- https://doi.org/10.1016/j.eprac.2021.11.081
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Are All Estrogens Created Equal? A Review of Oral vs. Transdermal TherapyJournal of Women's Health, 2012
- Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysisBMJ, 2008
- Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy: Comparison of Transdermal and Oral Administration in a Crossover-Designed StudyGynecologic and Obstetric Investigation, 2007
- Pharmacology of estrogens and progestogens: influence of different routes of administrationClimacteric, 2005
- Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism riskThe Lancet, 2003
- Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein CBlood Coagulation & Fibrinolysis, 2000
- Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17β-estradiolObstetrics & Gynecology, 1997
- Pharmacokinetic and Pharmacologic Variation Between Different Estrogen ProductsThe Journal of Clinical Pharmacology, 1995